Action Required: Password Reset on Next Login
As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.
To reset your password, please visit the Reset Password page.
We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Nephris s.r.l.
BioCentury | May 13, 2022
Finance
In latest Italy deal, Sofinnova seeds nanodelivery start-up NanoPhoria with €3.5M
Targeted, non-viral drug delivery start-up is eighth deal for European firm’s Italy-focused Telethon Fund
BioCentury | May 13, 2022
Data Byte
Distillery spotlight on Italian innovation
Opportunities include compounds and targets for cancer, neurology and musculoskeletal diseases, and discoveries from company founders
BioCentury | Apr 29, 2022
Finance
Two years into Telethon Fund, Sofinnova builds Italy portfolio as ecosystem matures
European firm’s Seghezzi: Momentum building for scientific deal flow as region draws funding, teams, infrastructure
BioCentury | Apr 21, 2022
Deals
April 21 Quick Takes: Reify’s big round to support clinical trial diversity
Plus Terran gains rights to two late-stage candidates from Sanofi, and updates from Ampio, Nephris, Jacobus and more
Items per page:
1 - 4 of 4